T2DM patients are often treated with high insulin doses leading to weight gain and high blood pressure and, despite intensified insulin therapy, the treatment goals, which also include improved metabolic control and tight blood pressure control, are not reached. The gene discussed is INS; the disease is hypertensive disorder.